CRENGINE and Samsung Medical Center File Joint Patent on VR-Based Interaction Control for Emotion Relief
A result of the joint study on VR content for cancer-patient distress: a method and device for controlling VR-based interaction to relieve emotions.
On December 12, 2025, CRENGINE and Samsung Medical Center jointly filed a patent for 'a method and device for controlling virtual-reality-based interaction for emotion relief' (application no. 10-2025-0197833).
Since 2024 the two organizations have co-developed VR content that assesses and relieves the psychological distress of cancer patients — combining CRENGINE's real-time interaction and 3D object control technology with the clinical know-how of Samsung Medical Center.
Next stepsClinical trials (Samsung Medical Center), overseas paper publication, GMP certification and commercialization, aiming at the digital therapeutics market.